Axonics (NASDAQ:AXNX) said it acquired a lead placement solution from Radian which complements the company's existing sacral neuromodulation (SNM) offering. The company acquired the assets of Radian ...
This x-ray of the pelvis shows an electronic nerve-stimulating device in the right iliac fossa. The procedure is ideal in this population because it is minimally invasive and highly efficacious The ...
Pivotal Study Data Show Comparable “Gold Standard” Efficacy to Traditional Sacral Neuromodulation (SNM) Devices – Eliminating Burdens of a Battery Implant In a market that has gradually grown to $1 ...
Medical technologies guidance 50 has been migrated to HealthTech guidance 554. The recommendations and accompanying content remain unchanged. This guidance replaces the NICE medtech innovation ...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel ...
SAN JOSE, Calif., June 18, 2025 /PRNewswire/ -- Neuspera ® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, today announced that the U.S. Food ...
Boston Scientific kicked off one of the most important healthcare conferences of the year (J.P. Morgan) with a $3.7 billion deal to bolster its urology portfolio. The Marlborough, MA-based company has ...
1 randomised controlled trial (5 publications: McVary et al. 2019, McVary and Roehrborn 2018, Roehrborn et al. 2017, McVary et al. 2016a, McVary et al. 2016b) 1 prospective observational study (3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback